{"count": 2, "results": [{"_id": "24896141", "pmid": 24896141, "title": "A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy.", "journal": "Am J Perinatol", "authors": ["Refuerzo JS", "Gowen R", "Pedroza C", "Hutchinson M", "Blackwell SC", "Ramin S"], "date": "2015-02-01T00:00:00Z", "doi": "10.1055/s-0034-1378144", "meta_date_publication": "2015 Feb", "meta_volume": "30", "meta_issue": "2", "meta_pages": "163-70", "score": 50051.914, "text_hl": "There was one case of @DISEASE_Fetal_Macrosomia @DISEASE_MESH:D005320 @@@fetal macrosomia@@@ in the @GENE_INS @GENE_3630 @@@insulin@@@ group, one case of @<m>DISEASE_Shoulder_Dystocia</m> @DISEASE_MESH:D000080883 @@@shoulder dystocia@@@ in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group and no cases of failed @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy. ", "citations": {"NLM": "Refuerzo JS, Gowen R, Pedroza C, Hutchinson M, Blackwell SC, Ramin S. A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy. Am J Perinatol. 2015 Feb;30(2):163-70. PMID: 24896141", "BibTeX": "@article{24896141, title={A pilot randomized, controlled trial of metformin versus insulin in women with type 2 diabetes mellitus during pregnancy.}, author={Refuerzo JS and Gowen R and Pedroza C and Hutchinson M and Blackwell SC and Ramin S}, journal={Am J Perinatol}, volume={30}, number={2}, pages={163-70}}"}}, {"_id": "30039871", "pmid": 30039871, "title": "Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.", "journal": "Cochrane Database Syst Rev", "authors": ["Dodd JM", "Grivell RM", "Deussen AR", "Hague WM"], "date": "2018-07-24T00:00:00Z", "doi": "10.1002/14651858.CD010564.pub2", "meta_date_publication": "2018 Jul 24", "meta_volume": "7", "meta_issue": "7", "meta_pages": "CD010564", "score": 50040.918, "text_hl": "No other important differences were identified between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and placebo for other maternal secondary outcomes, including: caesarean birth, birth before 37 weeks of pregnancy, @<m>DISEASE_Shoulder_Dystocia</m> @DISEASE_MESH:D000080883 @@@shoulder dystocia@@@, @DISEASE_Neuralgia @DISEASE_MESH:D009437 @@@perineal tear@@@, or @DISEASE_Postpartum_Hemorrhage @DISEASE_MESH:D006473 @@@postpartum haemorrhage@@@.In terms of other infant outcomes, there was little or no difference in the infant birthweight (MD 6.39 g, 95% CI -81.15 to 93.92; 2 studies, 834 @SPECIES_9606 @@@infants@@@; high-quality evidence). ", "citations": {"NLM": "Dodd JM, Grivell RM, Deussen AR, Hague WM. Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes. Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. PMID: 30039871", "BibTeX": "@article{30039871, title={Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.}, author={Dodd JM and Grivell RM and Deussen AR and Hague WM}, journal={Cochrane Database Syst Rev}, volume={7}, number={7}, pages={CD010564}}"}}]}